ResearcherKarolinska University HospitalActive in the last 2 years
Jesper Lagergren
Matched on ORCID iD 0000-0002-5143-5448; OpenAlex author ID A5043761366. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 20
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Risk of pancreatic cancer after eradication treatment of Helicobacter pylori. Last author DOI 10.1016/j.ejca.2025.116192↗
- Pancreatic cancer is associated with medication changes prior to clinical diagnosis. Co-author DOI 10.1038/s41467-023-38088-2↗
- Reply to 'Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer''. Co-author DOI 10.1038/bjc.2016.100↗
- New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer. Co-author DOI 10.1038/bjc.2015.353↗
- Oral disease and risk of pancreatic cancer. Last author DOI 10.1097/ede.0b013e318225bf48↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Joonas H. Kauppila · 1 shared paper, 2026 · strength 0.30
- Cecilia Radkiewicz · 1 shared paper, 2026 · strength 0.30
- A.-K. Eriksson Wiklund · 1 shared paper, 2026 · strength 0.30
- Tomas Sjöberg Bexelius · 3 shared papers, 2011–2016 · strength 0.16
- Paper Reply to 'Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic canc… DOI 10.1038/bjc.2016.100↗
- Paper New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer. DOI 10.1038/bjc.2015.353↗
- Paper Oral disease and risk of pancreatic cancer. DOI 10.1097/ede.0b013e318225bf48↗
- Ana Babić · 1 shared paper, 2023 · strength 0.15
- Chen Yuan · 1 shared paper, 2023 · strength 0.15
- Michael Hayden Rosenthal · 1 shared paper, 2023 · strength 0.15
- Yin Zhang · 1 shared paper, 2023 · strength 0.15
- Alice A. Lee · 1 shared paper, 2023 · strength 0.15
- Edward L. Giovannucci · 1 shared paper, 2023 · strength 0.15
- Kimmie Ng · 1 shared paper, 2023 · strength 0.15
- Qiao-Li Wang · 1 shared paper, 2023 · strength 0.15
- Peter Kraft · 1 shared paper, 2023 · strength 0.15
- Brian Matthew Wolpin · 1 shared paper, 2023 · strength 0.15
- Jonathan Andrew Nowak · 1 shared paper, 2023 · strength 0.15
- Kimberly J. Perez · 1 shared paper, 2023 · strength 0.15
- Chris Sander · 1 shared paper, 2023 · strength 0.15
- Yunxia Lu · 2 shared papers, 2015–2016 · strength 0.12
- Linnéa Malgerud · 2 shared papers, 2015–2016 · strength 0.12
- Rickard Ljung · 1 shared paper, 2011 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.